Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.
Hiligsmann M, Dellaert BG, Dirksen CD, Watson V, Bours S, Goemaere S, Reginster JY, Roux C, McGowan B, Silke C, Whelan B, Diez-Perez A, Torres E, Papadakis G, Rizzoli R, Cooper C, Pearson G, Boonen A. Hiligsmann M, et al. Among authors: watson v. Rheumatology (Oxford). 2017 Jul 1;56(7):1167-1176. doi: 10.1093/rheumatology/kex071. Rheumatology (Oxford). 2017. PMID: 28398547 Free PMC article.
Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
Hifinger M, Hiligsmann M, Ramiro S, Watson V, Severens JL, Fautrel B, Uhlig T, van Vollenhoven R, Jacques P, Detert J, Canas da Silva J, Scirè CA, Berghea F, Carmona L, Péntek M, Keat A, Boonen A. Hifinger M, et al. Among authors: watson v. Ann Rheum Dis. 2017 Jan;76(1):126-132. doi: 10.1136/annrheumdis-2016-209202. Epub 2016 May 17. Ann Rheum Dis. 2017. PMID: 27190098 Free article.
Are Patients' Preferences Transferable Between Countries? A Cross-European Discrete-Choice Experiment to Elicit Patients' Preferences for Osteoporosis Drug Treatment.
Hiligsmann M, Dellaert B, Dirksen C, Van dW, Watson V, Goemaere S, Reginster JY, Bours S, Roux C, McGowan B, Silke C, Whelan B, Diez PA, Papadakis G, Torres E, Rizzoli R, Cooper C, Pearson G, Boonen A. Hiligsmann M, et al. Among authors: watson v. Value Health. 2014 Nov;17(7):A385. doi: 10.1016/j.jval.2014.08.2642. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200871 Free article. No abstract available.
329 results